Prognostic factors affecting early colectomy in patients with moderate to severe ulcerative colitis treated with calcineurin inhibitors

被引:8
|
作者
Ban, Hiromitsu [1 ]
Bamba, Shigeki [2 ]
Nishida, Atsushi [2 ]
Inatomi, Osamu [2 ]
Shioya, Makoto [2 ]
Takahashi, Ken-Ichiro [2 ]
Imaeda, Hirotsugu [2 ]
Murata, Masaki [2 ]
Sasaki, Masaya [3 ]
Tsujikawa, Tomoyuki [4 ]
Andoh, Akira [2 ]
机构
[1] Shiga Univ Med Sci, Div Endoscopy, Otsu, Shiga 5202192, Japan
[2] Shiga Univ Med Sci, Div Gastroenterol, Otsu, Shiga 5202192, Japan
[3] Shiga Univ Med Sci, Div Clin Nutr, Otsu, Shiga 5202192, Japan
[4] Shiga Univ Med Sci, Dept Comprehens Internal Med, Otsu, Shiga 5202192, Japan
关键词
ulcerative colitis; colectomy; calcineurin inhibitors; cyclosporine A; tacrolimus; INFLAMMATORY-BOWEL-DISEASE; NUTRITIONAL INDEX; RESCUE THERAPY; TNF-ALPHA; CYCLOSPORINE; INFLIXIMAB; CYTOMEGALOVIRUS; GUIDELINES; ADULTS; MANAGEMENT;
D O I
10.3892/etm.2016.3341
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Calcineurin inhibitors (CNIs) such as cyclosporine A (CSA) and tacrolimus (FK506) are often used as a second-line drug for steroid-refractory or steroid-dependent patients with ulcerative colitis (UC). The aim of the present study was to determine the prognostic factors for early colectomy. A total of 85 hospitalized patients with UC (CSA, 50 patients; FK506, 35 patients) were enrolled. Colectomy carried out within 60 days of starting CNI therapy was defined as. early colectomy'. To assess the prognostic factors affecting early colectomy, clinical practical variables, including the Onodera-prognostic nutritional index (O-PNI): 10xAlb+0.005x (total lymphocyte count), were analyzed. The results demonstrated that the significant factors predicting early colectomy were i) disease severity, ii) immunomodulator-naive history, iii) lower serum hematocrit, iv) lower serum albumin and v) lower O-PNI. In addition, the significant factors predicting overall colectomy were as follows: i) C7-HRP positivity and ii) >10,000 mg of prednisolone used prior to the initiation of CNI treatment. The combination of hematocrit and O-PNI enhanced the prediction of early colectomy. Clinical variables such as hematocrit and O-PNI were the significant factors predicting colectomy. These results may be used as a guide to predict the outcome of patients with UC in clinical settings.
引用
收藏
页码:829 / 834
页数:6
相关论文
共 50 条
  • [31] Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis
    Pellet, Gauthier
    Stefanescu, Carmen
    Carbonnel, Franck
    Peyrin-Biroulet, Laurent
    Roblin, Xavier
    Allimant, Christophe
    Nachury, Maria
    Nancey, Stephane
    Filippi, Jerome
    Altwegg, Romain
    Brixi, Hedia
    Fotsing, Ginette
    de Rosamel, Laure
    Shili, Sarah
    Laharie, David
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (03) : 494 - 501
  • [32] Does CT Influence the Decision to Perform Colectomy in Patients with Severe Ulcerative Colitis?
    Andre da Luz Moreira
    Jon D. Vogel
    Mark Baker
    Isabella Mor
    Ren Zhang
    Victor Fazio
    Journal of Gastrointestinal Surgery, 2009, 13 : 504 - 507
  • [33] MORBIDITY OF SUBTOTAL COLECTOMY IN PATIENTS WITH SEVERE ULCERATIVE-COLITIS UNRESPONSIVE TO CYCLOSPORINE
    FLESHNER, PR
    MICHELASSI, F
    RUBIN, M
    HANAUER, SB
    PLEVY, SE
    TARGAN, SR
    DISEASES OF THE COLON & RECTUM, 1995, 38 (12) : 1241 - 1245
  • [34] Biologics for the treatment of moderate-to-severe ulcerative colitis in pediatric patients
    Albenberg, Lindsey G.
    Mamula, Petar
    Kelsen, Judith R.
    PEDIATRIC HEALTH MEDICINE AND THERAPEUTICS, 2012, 3 : 51 - 58
  • [35] A Scoring System to Determine Patients' Risk of Colectomy Within 1 Year After Hospital Admission for Acute Severe Ulcerative Colitis
    Le Baut, Guillaume
    Kirchgesner, Julien
    Amiot, Aurelien
    Lefevre, Jeremie H.
    Chafai, Najim
    Landman, Cecilia
    Nion, Isabelle
    Bourrier, Anne
    Delattre, Charlotte
    Martineau, Chloe
    Sokol, Harry
    Seksik, Phillipe
    Nguyen, Yann
    Marion, Yoann
    Lebreton, Gil
    Carbonnel, Franck
    Viennot, Stephanie
    Beaugerie, Laurent
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (08) : 1602 - +
  • [36] Low-dose Infliximab for Induction and Maintenance Treatment in Chinese Patients With Moderate to Severe Active Ulcerative Colitis
    Jiang, Xue-Liang
    Cui, Hui-Fei
    Gao, Jing
    Fan, Hua
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 (07) : 582 - 588
  • [37] Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States
    Long, Millie D.
    Smith, Timothy W.
    Dibonaventura, Marco
    Gruben, David
    Bargo, Danielle
    Salese, Leonardo
    Quirk, Daniel
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (06) : 941 - 948
  • [38] Exogenous Alkaline Phosphatase for the Treatment of Patients with Moderate to Severe Ulcerative Colitis
    Lukas, Milan
    Drastich, Pavel
    Konecny, Michal
    Gionchetti, Paolo
    Urban, Ondrej
    Cantoni, Franco
    Bortlik, Martin
    Duricova, Dana
    Bulitta, Michael
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (07) : 1180 - 1186
  • [39] Concomitant 5-Aminosalicylate Therapy in Moderate-to-Severe Ulcerative Colitis Patients Escalated to Infliximab Is Not Beneficial
    Balram, Bhairavi
    Joshi, Harshad
    Wong, Karen
    Kroeker, Karen I.
    Dieleman, Levinus A.
    Halloran, Brendan P.
    Baumgart, Daniel C.
    Peerani, Farhad
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (11) : 3985 - 3992
  • [40] Predictors of emergency colectomy in patients admitted with acute severe ulcerative colitis
    Mokhele, N. N.
    Thomson, S. R.
    Watermeyer, G. A.
    SOUTH AFRICAN JOURNAL OF SURGERY, 2017, 55 (03) : 20 - 26